Datamonitor, a New York-based market analysis firm, noted in a report, published March 2001, of an industry shift towards "high-barrier-to-entry generic products, " or specialty generic pharmaceuticals.
One important event happened between the first speculation about Japan's entry into TPP back in 2010 and Mr. Abe's announcement on Friday: the March 11, 2011, earthquake and tsunami.